title: Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?
authors.affiliation: Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
authors.forename: Hiddo J
authors.initials: HJ
authors.lastname: Lambers Heerspink
authors.forename: Dick
authors.initials: D
authors.lastname: de Zeeuw
mesh_terms: D000419:Albuminuria / Q000175:diagnosis*; D015415:Biomarkers; D001794:Blood Pressure; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy / Q000652:urine*; D012107:Research Design; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers